Investor
Financial information, reports, calendar and more
Financial Calendar
2019
May
Interim Report Q1 – May 17, 2019
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q1 (May 17, 2019)